Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092843 · ClinicalTrials.gov registry record
Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 177
- Enrollment target
NCT03092843: Completed study, sponsored by The Cleveland Clinic.
NCT03092843 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03092843 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
Investigators aim to assess changes in exercise capacity and quality of life after septal myectomy in patient with hypertrophic cardiomyopathy.
Primary Outcome
Mild improvement in Quality of Life summary score (increase in 5 points) as measured by Kansas City Cardiomyopathy Questionnaire -KCCQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2023-03-30 |
What the finished NCT03092843 record still lists
NCT03092843 is an observational study that tracks outcomes without assigning an intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03092843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03092843 about?
NCT03092843 is a clinical study titled "Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM". Investigators aim to assess changes in exercise capacity and quality of life after septal myectomy in patient with hypertrophic cardiomyopathy.
What is the current status of trial NCT03092843?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2017-03-20. Estimated completion is 2023-03-30.
Who is sponsoring clinical trial NCT03092843?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI